Biotech & Health Tech
STAT+: Most-favored nations policy makes drugmakers rethink launches abroad
Drug companies seem to be looking for workarounds to protect their U.S. sales against Trump's "most-favored nations" policy:
Drug companies seem to be looking for workarounds to protect their U.S. sales against Trump's "most-favored nations" policy:
This is a summary of the story. Read the full article at Stat News (Biotech & Health Tech) ↗